Vaccine-preventable diseases continue to occur on American campuses. Based on the recommendations of the American College Health Association (ACHA) Vaccine Preventable Diseases Committee and the Advisory Committee on Immunization Practices (ACIP) Saint Joseph’s University requires the following immunizations:
- COVID-19 vaccine – Series of 2 doses of Pfizer or Moderna, or one dose of Johnson & Johnson (Jansen). See below for WHO COVID-19 vaccines.
- MMR (Measles, Mumps, and Rubella) – Immunization with two doses of MMR, given on or after the first birthday and separated by at least one month.
- Tetanus/Diphtheria– Three doses of tetanus/diphtheria are required with a booster given within the past ten years.
- Polio– Three doses; Booster only if needed for travel.
- Meningococcal Meningitis Vaccine (conjugated) – One dose, on or after age 16 years, required for students living in University-owned housing (Pennsylvania State Law). Students must complete a written waiver if declining meningitis vaccination.
- Varicella Vaccine (Chicken Pox): Two doses of varicella-containing vaccine at least 12 weeks apart if vaccinated between 1 and 12 years of age and at least 4 weeks apart if vaccinated at age 13 years or older.
- Tuberculosis Testing/PPD (within the past year)- Recommended for all students; required for:
- Education Majors
- Anyone who has lived in or visited South America, Central America, Eastern Europe, Asia or Africa in the last 5 years.
- Students in contact with a known case.
- A chest x-ray is required if the student has had tuberculosis, has a positive reaction or has a past known positive PPD.
The CDC recommends to wait 4 weeks after receiving the COVID Vaccine to receive both a ppd (skin test) or an IGRA (blood test). Please contact the Health Center if you have any questions.
Immunization records must be complete and on file in the Student Health Center in order to register for classes. For religious or medical exemptions for non-COVID-19 vaccines please call the Student Health Center. For religious or medical exemptions for the COVID-19 vaccine, see the below information regarding the COVID-19 vaccine.
- Hepatitis B – Series of 3 doses; 0, 1-2mo., 6-12 months.
- Hepatitis A – Series of 2 doses; 0, 6-12 months.
- Meningococcal B. vaccine
- Bexsero: Series of 2 doses
- Trumenba: Series of 3 doses
COVID-19 VACCINE REQUIREMENT FOR ALL STUDENTS, FACULTY AND STAFF
The health and safety of our entire campus community are of paramount importance. We also desire to return fully to a more normal and vibrant on-campus experience, with limited need for testing, isolation, and other mitigation efforts. Accordingly, the University will require all students, faculty, and staff to be fully vaccinated against COVID-19 before participating in any on-campus activity related to the 2021-22 academic year. If you are unable to obtain the vaccine in your current location, we will help you do so when you arrive in Philadelphia. Complete this form to submit your COVID-19 Vaccine Verification by August 16. Beginning July 6, 2021 community members will have the ability to submit a medical or religious exemption.
- COVID-19 VACCINE:
- As of May 13, 2021, WHO has listed the following COVID-19 vaccines for emergency use:
Pfizer-BioNTech COVID-19 vaccines (e.g., COMIRNATY, Tozinameran)
AstraZeneca-Oxford COVID-19 vaccines (e.g., Covishield, Vaxzevria)
Janssen (Johnson & Johnson) COVID-19 vaccine
Moderna COVID-19 vaccine
Sinopharm COVID-19 vaccine
Sinovac COVID-19 vaccine
COVID-19 vaccines not authorized by FDA but listed for emergency use by the World Health Organization (WHO)
People who have received all recommended doses of a COVID-19 vaccine that is listed for emergency use by WHO do not need any additional doses with an FDA-authorized COVID-19 vaccine.
People who have not received all the recommended doses of a COVID-19 vaccine listed for emergency use by WHO may be offered a complete FDA-authorized COVID-19 vaccine series.
COVID-19 vaccines neither authorized by FDA nor listed for emergency use by WHO
People who received all or some of the recommended doses of a COVID-19 vaccine that is neither authorized by FDA nor listed for emergency use by WHO may be offered a complete FDA-authorized COVID-19 vaccine series.
The minimum interval between the last dose of a non-FDA authorized vaccine or a WHO-listed vaccine and an FDA-authorized COVID-19 vaccine is 28 days. Only people who have received all recommended doses of an FDA-authorized or WHO-listed COVID-19 vaccine are considered fully vaccinated for the purpose of public health guidance.
The Centers for Disease Control website has many resources for students and families to research the safety, efficacy and benefits of vaccination.